AI Telemedicine Platform Designer Interview Questions

A strong answer explains FHIR as an interoperability standard, its resource-based model, and how it enables data exchange between telehealth apps and EHR systems.

Should cover real-time video/audio (synchronous) vs. store-and-forward, messaging, and remote patient monitoring (asynchronous) with clinical use cases.

Expect discussion of Privacy Rule, Security Rule, and Breach Notification Rule, and how each impacts platform architecture.

Should describe CDSS as software that provides clinicians with knowledge and patient-specific recommendations, and how LLMs can augment reasoning.

Great answers connect health literacy to patient comprehension, platform accessibility, plain-language design, and avoiding jargon in AI-generated content.

Should cover intent classification, symptom severity scoring, safety-critical escalation logic, and integration with clinical triage protocols like the Schmitt-Thompson guidelines.

Expect discussion of RAG architecture retrieving patient context from FHIR, real-time transcription pipelines, structured output generation, and clinician review workflows.

Should compare FHIR support, native AI/ML integrations, pricing models, compliance certifications, and ecosystem maturity.

Should cover multilingual LLM capabilities, translation pipeline design, cultural sensitivity in medical terminology, and fallback strategies for low-resource languages.

Strong answers discuss confidence thresholds, clinician override capabilities, feedback loops for model improvement, and regulatory expectations for AI-assisted diagnosis.

Should explain SMART as an app launch framework, OAuth 2.0 authorization, and how it enables modular, interoperable clinical applications.

Expect discussion of benchmarking against ICD-10 mappings, sensitivity/specificity metrics, clinical expert panel review, and iterative testing with real or synthetic patient cases.

Should cover WebRTC fundamentals (peer-to-peer, low latency), and AI overlays like live transcription, emotion detection, real-time clinical note generation, and visual AI for dermatology.

Should discuss RBAC/ABAC patterns, least-privilege principles, audit trail design, and FHIR consent resource management.

Strong answers explain SaMD classification (I, II, III), the FDA's predetermined change control plan for AI/ML, and the distinction between clinical decision support that is and isn't regulated.

Expect a system architecture with patient intake AI, FHIR data layer, clinician dashboard, monitoring pipeline (wearables → edge processing → cloud analytics), and clear HIPAA compliance boundaries.

Should cover grounding via RAG with verified clinical sources, output confidence scoring, entity fact-checking against structured data, mandatory human review for high-stakes decisions, and post-deployment monitoring.

Should discuss conformity assessments, data governance for training data, transparency and explainability obligations, human oversight mandates, and post-market surveillance.

Expect discussion of FHIR Condition, Observation, and CarePlan resources; temporal reasoning in LLM context windows; summarization strategies; and EHR reconciliation.

Should cover demographic parity analysis, stratified performance metrics, training data auditing, fairness-aware model evaluation, and community health input loops.

Should cover LangGraph-style orchestration, agent communication protocols, shared memory/context stores, conflict resolution between agents, and safety boundaries.

Expect discussion of intended use, limitations, training data provenance, performance across subgroups, known failure modes, and update/versioning governance.

Should cover streaming ASR (Whisper, Deepgram), real-time entity extraction, structured note generation aligned with SOAP format, and optimized clinician review UX.

Should discuss streaming ingestion (Kafka/Kinesis), time-series anomaly detection, clinical threshold alerting, FHIR Observation mapping, and clinician notification prioritization.

Strong answers address A/B testing design in clinical settings, outcome metrics (readmission rates, time-to-diagnosis, patient satisfaction), statistical significance, and ethical considerations of control groups.

Should cover incident root cause analysis, model input/output logging review, clinical guideline comparison, immediate safety patches, long-term retraining, and regulatory notification procedures.

Expect discussion of edge AI inference, compressed models, offline-first design, SMS/USSD fallback channels, local language support, and solar-powered device considerations.

Should cover Epic's App Orchard/Open.Epic program, SMART on FHIR integration, phased rollout with pilot clinicians, change management, and demonstrating ROI through data.

Should discuss output validation against medication databases (RxNorm, NDC), constrained decoding or post-processing, structured extraction vs. free text generation, and clinician safety checks.

Expect discussion of attention visualization, retrieval source attribution, structured reasoning chains, patient-friendly summaries, and layered explainability for different stakeholders.

Should cover crisis detection and escalation to human counselors, content safety filters, session boundary awareness, clinical oversight, informed consent design, and self-harm risk protocols.

Should discuss confidence threshold policies, immediate dermatologist review routing, patient communication protocols, documentation standards, and follow-up scheduling.

Expect discussion of regulatory risk of autonomous diagnosis, differentiated positioning as AI-augmented clinician workflows, patient safety messaging, and competitive feature roadmap.

Should cover infrastructure profiling, LLM inference scaling (batching, model optimization, caching common queries), async processing patterns, and graceful degradation strategies.

Should discuss age-appropriate language, parent-proxy input validation, pediatric clinical guidelines (different vital sign ranges, dosage calculations), COPPA compliance, and consent workflows.

Should detail chain design: symptom extraction → differential diagnosis generation → guideline retrieval via RAG → severity scoring → recommendation with confidence and escalation logic.

Expect discussion of JSON schema enforcement, function definitions for clinical tools, retry logic for malformed outputs, and integration with downstream FHIR Condition resources.

Should cover data de-identification pipeline (Philter, Presidio), annotation guidelines, train/eval split strategy, hyperparameter tuning, evaluation against NER benchmarks, and deployment via Hugging Face Inference Endpoints.

Should cover document chunking strategies for clinical guidelines, embedding model selection (PubMedBERT, text-embedding-3-large), vector store choice (Pinecone, Weaviate), retrieval filtering by specialty/recency, and answer generation with source citations.

Should cover SageMaker in VPC with private endpoints, encrypted S3 model artifacts, CloudTrail audit logging, model registry, canary deployment, and CloudWatch-based drift/alerting dashboards.

Expect discussion of model card evaluation, benchmarking on medical summarization datasets (MIMIC-CXR reports, i2b2), latency profiling, model size vs. accuracy tradeoffs, and inference cost analysis.

Should cover agent tool design (FHIR query functions), context window management for large patient histories, summarization prioritization (active problems, medications, recent labs), and output formatting for clinician dashboards.

Should cover streaming ASR integration (Whisper API, Deepgram), speaker diarization (patient vs. clinician), real-time entity extraction pipeline, SOAP section classification, and post-call note generation with clinician review UI.

Should discuss protocol encoding into system prompts, few-shot example curation from validated triage scenarios, chain-of-thought prompting for clinical reasoning, and systematic prompt regression testing.

Should cover LLM-as-judge for clinical accuracy, ground-truth benchmark datasets, safety regression tests, clinician-rated evaluation panels, and continuous eval integration into CI/CD pipelines.

Strong answers show principled decision-making, stakeholder communication, phased rollout strategies, and a clear prioritization of patient safety while still delivering business value.

Expect demonstration of empathy for clinical expertise, willingness to iterate, evidence-based negotiation, and ability to translate between technical and clinical mental models.

Should describe structured incident response, transparent communication with stakeholders, root cause analysis, and implementation of systematic safeguards.

Strong answers reference specific papers, conferences (AMIA, HIMSS), communities, or tools, and connect them to concrete architectural or design changes.

Expect evidence of user research, inclusive design practices, humility about assumptions, and tangible design changes driven by user insights.